Celigo Imaging Cytometer

Added: Jun 21, 2018 10:51 am
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Nexcelom Biosciences LLC. to procure Celigo Imaging Cytometer.

The Imaging instrument will be used in support of ongoing research at the Vaccine Research Center (VRC) for vaccine development. The essential method for vaccine development is cell and viral infectivity imaging of invitro models to assess the efficacy of a given vaccine candidate. The high-content imaging required is provided by the Celigo Imaging Cytometer. Place of delivery is 40 Convent Drive, Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-1914933) to Laura Grey at laura.grey@nih.gov, by 5:00 pm eastern standard time 5:00 PM eastern standard time, July 5, 2018. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.